David Moadel

David Moadel

Expertise: Stocks, Options, Precious metals, Bitcoin, Altcoins

Education: Master's degree in education from the American College of Education, Bachelor's degree in education from Florida Atlantic University, Associate's degree in liberal arts from Palm Beach Community College

About David:
David Moadel is a financial writer for InvestorPlace.com. He has a master’s degree in education and has authored financial content for multiple websites.

David is also active as a social media influencer, with tens of thousands of followers on YouTube, Twitter, StockTwits, and other popular sites. David writes on topics ranging from stocks to cryptocurrencies, options, precious metals, bonds, futures, and other areas of finance.

Focusing on data rather than emotions, David is always on the lookout for new pathways to financial freedom. Count on David for wealth-building strategies and resources for investors and traders of all financial backgrounds.

You can follow David on YouTube, Twitter, StockTwits and LinkedIn.

Recent Articles

China Mobile Stock Offers Both Income and Price Appreciation Potential

It's probably not on most American traders' top-10 lists of dividend darlings, but CHL stock is an emerging-market value play worth watching.

Don’t Let Trade Tensions Worry You About Alibaba Stock

With Alibaba continuing to grow by leaps and bounds, BABA stock holders shouldn't feel the need to concern themselves with every headline.

Norwegian Cruise Line Shares Will Stumble Until the World Has a Vaccine

Prepare for rough seas as external forces will push Norwegian Cruise Line stock to and fro for a while, making it difficult to stay afloat.

The Mainstreaming of Cannabis Is Here and Canopy Growth Is a Strong Buy

A famous lifestyle guru just took the plunge into cannabis-based goods. This is a win for the pro-hemp movement and for CGC stock holders.

Put the Analytics Revolution in Your Portfolio with Alteryx Stock

Beaten-down AYX stock could be considered dead money, or it could be a chance to capitalize on an underappreciated analytics-market gem.

DNA Vaccine Gives Inovio Pharmaceuticals Stock a Long Shelf Life

INO stock traders may be skeptical about Inovio's main Covid-19 vaccine candidate, but the CEO made a convincing case to stay in the trade.

This Billion-Dollar Acquisition Will Be Worth It for Ericsson Investors

It's understandable if you want to hitch your wagon to 5G's future growth, and buying Ericsson stock is an easy way to do just that.

Kensington Capital Could Be a Breakout Star in the Electric Car Space

Not everyone's heard of Kensington Capital stock yet, but traders will be forced to pay attention as this isn't your ordinary shell company.

Improving Sales Trajectory Makes Nio Even More Attractive

Vehicle deliveries are the lifeblood of automakers, and Nio stock's ascent should continue as long as the company's sales figures stay up.

Pursue the Urban-Commuter Market With Kandi Technologies Stock

You might enjoy some sweet profits with a long position in Kandi Technologies stock, an unusual but compelling electric-car investment.